BASALIN
LIVE

Serial Number

79136321

Owner

Gan & Lee Pharmaceuticals Ltd.

Attorney

Andrew T. Rissler

Filing Date

Jul 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

BASALIN Trademark

Serial Number: 79136321 • Registration: 4615574

BASALIN is a trademark filed by Gan & Lee Pharmaceuticals Ltd. on July 25, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Gan & Lee Pharmaceuticals Ltd.

No. 8 Jingsheng North 3rd Street,

Entity Type: 99

Gan & Lee Pharmaceuticals. (13 trademarks)

No. 8 Jingsheng North 3rd Street,

Entity Type: 98

Trademark Details

Filing Date

July 25, 2013

Registration Date

October 7, 2014

Published for Opposition

July 22, 2014

Goods & Services

Medicines for human purposes, namely, insulin; raw material medicine, namely, insulin; Biomedicine for treating diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines cognitive disorders; chemical preparations for medical purposes, namely, for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical purposes, namely, for the treatment of endocrine related diseases and disorders; Pharmaceutical preparations, namely, insulin for injection; [ dietetic substances, namely, dietetic sugar, pasta and crackers adapted for medical use; ] drugs, namely, anti-diabetic pharmaceuticals for medical purposes

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 7, 2025 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 7, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 7, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Jan 24, 2025 NREP
TEAS SECTION 71 RECEIVED
Nov 7, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 7, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
May 12, 2023 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 3, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 27, 2021 INPS
INVALIDATION PROCESSED
Sep 27, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 11, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 11, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
Jan 11, 2021 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 10, 2021 APRE
TEAS SECTION 71 RECEIVED
Oct 2, 2020 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 7, 2019 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 7, 2017 ADCH
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jun 2, 2015 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 1, 2015 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 3, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 11, 2015 FICS
FINAL DISPOSITION PROCESSED
Mar 11, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 7, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 7, 2014 R.PR
NOTIFICATION PROCESSED BY IB
Jul 22, 2014 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 22, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 22, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 2, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 2, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 19, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2014 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 18, 2014 RCCK
ASSIGNED TO LIE
Jun 11, 2014 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2013 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2013 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2013 TEME
REFUSAL PROCESSED BY IB
Dec 10, 2013 RFNT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2013 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 18, 2013 RFCS
REFUSAL PROCESSED BY MPU
Nov 18, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2013 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 15, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 3, 2013 REPR